However, we found that in human pDCs, the expression of CH25H, SOCS1 and COP1 is significantly increased in the presence of high IFN response-inducing activation signals and we found that the levels of these inhibitory molecules are significantly higher in pDCs from psoriasis patients with high type I IFN levels compared with those from healthy controls. Here, COP1 is linked to psoriasis.